Biotech News

Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Talphera Inc (TLPH)TalpheraEarnings

SAN MATEO, Calif., Nov. 4, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a conference call and

Related news

Talphera Inc

Critical-Care Therapeutics Talphera develops hospital-based therapies intended to improve medication delivery in acute and critical-care settings. Its lead program addresses anticoagulation during continuous renal replacement therapy. Niyad Niyad is a regional citrate anticoagulant designed for use in the extracorporeal circuit during...

Recent company news

Stock data

Close
0.74 USD
Market cap
40.24M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States